Chemical Business Newsbase articles from August 2010

Chemical Business Newsbase archives from August 2010

EMS-GRILTECH to increase sales prices of Primid cross linkers.
August 31, 2010... EMS-GRILTECH will globally increase the prices of its range of Primid cross linkers and selective Grilonit powder coating additives. The new prices will take effect 1 Oct 2010. The escalating cost of raw materials has necessitated this action.

Small talk: Britain's only listed potash miner signs deal with Chinese.
August 31, 2010... In the week beginning 23 Aug 2010, Sirius Exploration announced that it had penned a memorandum of understanding (MOU) with state-owned Sino-Agri (a Chinese company) to help bring its Queensland development into production. Sirius's deal with...

Small talk: Nautilus seeks undersea treasure.
August 31, 2010... To the casual observer, mining is, of course, all about digging holes in the ground and taking out whatever is found there. Not, however, if you talk to Nautilus Minerals. The Aim-listed company has decided that the seabed can be just as...

Protesters shut down 'dangerous' Arctic oil drill.
August 31, 2010... Environmental campaigners today claimed to have shut down a "dangerous" oil drilling operation by a British energy company in the Arctic. Greenpeace said four expert climbers in inflatable speedboats had evaded Danish navy commanders to climb up...

Why failure of climate summit would herald global catastrophe: 3.5 degC.
August 31, 2010... The world is heading for the next major climate change conference in Cancun later in 2010 on course for global warming of up to 3.5 degC in the coming century, a series of scientific analyses suggest. The failure of last Dec 2009's UN climate...

Nanotech helping 3D TVs slim down for a bigger, better pictures.
August 31, 2010... LG Electronics will show off the world's slimmest full LED 3D TV at the IFA consumer electronics trade show in Berlin from 3-8 Sep 2010. The amazingly thin design and high quality picture is enabled through the inclusion of LG's NANO Lighting...

Lyondell-Basell's new plant onstream.
August 31, 2010... Lyondell-Basell has commissioned its new HDPE plant in Muenchmuenster. The plant has capacity of 320,000 tonnes/y and employs 65.

Sabic and Lurgi sign deal for construction of a bioalcohol plant.
August 31, 2010... Sabic has signed a deal with Lurgi GmbH for an oleochemicals plant that will use a Lurgi process. Once completed in Jubail at the end of 2013, the plant will be used operated by Sabic subsidiary Saudi Kayan Petrochemical. The process will use...

Iran planning two petrochemicals plants.
August 31, 2010... Iran is to erect two petrochemicals plants in cooperation with an unnamed Turkish company. In addition to a 1.65 M tonnes/y methanol unit, there are plans for a plant that will produce 539,000 tonnes/y of petrochemical products. Iran wants to...

Opinion following an Article 781 procedure for Pregsure BVD and associated names.
August 31, 2010... Pregsure BVD is an inactivated vaccine for the immunisation of cattle at breeding age to prevent bovine viral diarrhoea virus type 1 (cytopathogenic strain 5960) transplacental infection and the birth of bovine viral diarrhoea virus type 1...

FDA seeks court order against Michigan dairy: Government alleges cattle sold for human consumption contained illegal drug residues.
August 31, 2010... On 31 Aug 2010, the US Department of Justice, on behalf of the US Food and Drug Administration, has filed a complaint for permanent injunction against Scenic View Dairy of Hamilton, Mich, its president, and three of its managers alleging that...

New and generic drug approvals: Phendimetrazine Tartrate Oral Tablet, KVK Tech.
August 31, 2010... On 31 Aug 2010, the US Food and Drug Administration announced approval of ANDA 090142 for Phendimetrazine Tartrate Oral Tablet. The product contains phendimetrazine tartrate at 35mg, is manufactured by KVK Tech, and is prescription only. There...

New and generic drug approvals: Lumigan Ophthalmic Solution, Allergan.
August 31, 2010... On 31 Aug 2010, the US Food and Drug Administration announced approval of NDA 022184 for Lumigan Ophthalmic Solution. The product contains bimatoprost at 0.01%, is manufactured by Allergan, and is prescription only. There are no therapeutic...

New and generic drug approvals: Travatan Z Ophthalmic Solution, Alcon.
August 31, 2010... On 31 Aug 2010, the US Food and Drug Administration announced approval of NDA 021994 for Travatan Z Ophthalmic Solution. The product contains travoprost at 0.004%, is manufactured by Alcon, and is prescription only. There are no therapeutic...

New and generic drug approvals: Travatan Ophthalmic Solution, Alcon.
August 31, 2010... On 31 Aug 2010, the US Food and Drug Administration announced approval of NDA 021257 (efficacy supplement with clinical data to support) for Travatan Ophthalmic Solution. The product contains travoprost at 0.004%, is manufactured by Alcon, and...

Dr Reddy's to sell Quetiapine in NZ.
August 31, 2010... The drug funding agency of New Zealand (NZ) Government Pharmac has grated permission to the Hyderabad-based Dr Reddy's Laboratories Ltd (Dr Reddy's) to sell Quetiapine in New Zealand. Quetiapine is indicated in the treatment of maniac and...

Jubilant signs $33 M contract manufacturing deal with US company.
August 31, 2010... Jubilant Organosys Ltd, has signed a contract manufacturing contract worth $33 M for an initial period of four and a half years with a US-based life sciences firm. The product to be manufactured is an in-house developed product with captively...

Domestic oil products sales up 2% in Jul 2020.(Financial report)
August 31, 2010... Oil products sale in India was higher by 2% at 11.42 M tonnes for Jul 2010. Sales of petrol were higher by 14.8% at 1.16 M tonnes and that of diesel by 5.6% at 4.8 M tonnes for Jul 2010 whereas sales of kerosene, lubricants and bitumen were...

Continental plans to enter passenger car tyre market.
August 31, 2010... Continental AG is in talks with several Indian tyre manufacturers for a tie-up to foray into the passenger car tyres segment in India. The company has already a tie up with the Modi Group to manufacturer tyres for commercial vehicle tyres. The...

Aevum Bio Labs has promising molecules.
August 31, 2010... The Dubai-based Aevum Bio Labs, promoted by Indians, has developed two promising drug candidates to treat AIDS and Amiotropic Lateral Sclerosis, a neurological disorder. The company has identified a synthetic molecule which has shown promise in...

Sangart Inc reports positive Phase IIa data for novel oxygen therapeutic agent MP4OX in severe trauma patients.(Clinical report)
August 31, 2010... Sangart Inc announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated haemoglobin) in severely injured trauma patients with haemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX,...

Compendia Bioscience awarded $1.3 M in SBIR fast track funds.
August 31, 2010... Compendia Bioscience Inc announced the award of $1.3 M in SBIR fast track funds to incorporate micro-RNA data and analyses into the Oncomine platform. Cancer is a highly complex disease in which all of the causes and effects are not well...

MonoSol announces Reckitt Benckiser FDA approval of Suboxone sublingual film for treatment of opioid dependence.
August 31, 2010... MonoSol Rx announced that its partner Reckitt Benckiser Pharmaceuticals Inc (Reckitt Benckiser) has received approval from the US Food and Drug Administration (FDA) to market Suboxone (buprenorphine HCl/naloxone HCl dihydrate) sublingual film...

An expanding aging population and increases in diagnosis and drug treatment will fuel steady 4.6%/y growth in the chronic obstructive pulmonary drug market.
August 31, 2010... Decision Resources, one of the world 's leading research and advisory firms for pharmaceutical and healthcare issues finds that, through 2019, an expanding aging population and increases in diagnosis and drug treatment will fuel steady 4.6%/y...

Reportlinker adds men 's health therapeutics market to 2016 - selective serotonin reuptake inhibitors, hormone replacement therapy and Phosphodiesterase type-5 inhibitors will dominate the market.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: Selective-serotonin-reuptake-inhibitors-hormone-replacement-therapy-and-pho sphodiesterase-type-5-inhibitors-will-dominate-the-market. GBI Research has...

Reportlinker adds women 's infertility - pipeline assessment and market forecasts to 2017.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: Women 's Infertility - Pipeline Assessment and Market Forecasts to 2017. GlobalData, the industry analysis specialist, has released its new report,...

ScinoPharm to invest in Tanvex Biologics.
August 31, 2010... ScinoPharm Taiwan (ScinoPharm) announced an investment into Tanvex Biologics Inc (Tanvex). ScinoPharm 's investment was in the form of tangible assets, intellectual properties, as well as cash. Tanvex specializes in the development of...

Reportlinker adds cardiovascular generic drugs: prospects and opportunities to 2012.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: Cardiovascular Generic Drugs: Prospects and Opportunities to 2012. With a number of first line therapies coming off-patent by 2015 the prospects for...

Reportlinker adds erectile dysfunction - pipeline assessment and market forecasts to 2017.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017. GlobalData 's pharmaceutical and healthcare report, 'Erectile Dysfunction -...

Reportlinker adds hormone replacement therapy in menopause - pipeline assessment and market forecasts to 2017.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: hormone replacement therapy in menopause - pipeline assessment and market forecasts to 2017. The report is an essential source of information and...

Reportlinker adds threats to avastin - targeting the VEGF pathway.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: Threats to Avastin - Targeting the VEGF Pathway. Avastin is set to become the most successful cancer treatment to date and one of the leading drugs with...

Reportlinker adds the outlook for pharmaceuticals in the Middle East and North Africa to 2015.
August 31, 2010... Reportlinker.com announces that a new market research report is available in its catalogue: The outlook for pharmaceuticals in the Middle East and North Africa to 2015. Attractive macro-environmental conditions Political, economic, social and...

Glenmark announces the discovery of a novel chemical entity 'GRC 17536 ', a TRPA1 receptor antagonist, a potential first-in-class molecule globally.
August 31, 2010... Glenmark announced the discovery of a Novel Chemical Entity (NCE) 'GRC 17536 '. The new NCE programme is targeting TRPA1 receptor antagonists for pain and respiratory disorders. TRPA1 belongs to Transient Receptor Potential (TRP) family of ion...

Westlake Chemical to commence construction of Chlor-Alkali Plant.
August 31, 2010... Westlake Chemical Corp (Westlake) announced that it is proceeding with the previously announced construction of a new chlor-alkali plant to be located at its vinyls manufacturing complex in Geismar, LA. The new chlor-alkali unit is estimated to...

MarketsandMarkets: Renewable Chemicals Market Worth $67.13 bn in 2015.
August 31, 2010... According to the new market research report, 'Renewable Chemicals Market: Winning Imperatives & Market Forecast ' the renewable chemicals market is expected to grow at an estimated CAGR of 11.66% from 2010 to 2015 and is expected to reach to...

Zero discharge sweet sorghum ethanol process development.
August 31, 2010... AdvanceBio LLC (AdvanceBio), a Cincinnati-based advanced biofuel technology company, announced the development of its next generation, sugar-based fuel ethanol process. The process is capable of utilizing sugars derived from sugar cane, sweet...

Frost & Sullivan recognizes Solegear for pioneering Polysole Bioplastic.
August 31, 2010... Based on its recent analysis of the biopolymers market, Frost & Sullivan recognizes Solegear Bioplastics Inc (Solegear) with the 2010 North American Frost & Sullivan Award for New Product Innovation of the Year for its Polysole...

Spectra Energy completes acquisition of Bobcat gas storage assets.
August 31, 2010... Spectra Energy Corp (Spectra Energy) has completed the previously announced $540 M acquisition of the Bobcat Gas Storage assets and development project (Bobcat) from Haddington Energy Partners III LP and GE Energy Financial Services. The company...

InterOil announces agreement to settle long-standing lawsuit.
August 31, 2010... InterOil Corp has announced that it has entered into an agreement to settle all claims against it and its subsidiaries brought by various plaintiffs in the District Court of Montgomery County, TX, which commenced in 2005. The plaintiffs are...

First Uranium temporarily closes Ezulwini uranium plant for column replacement.(Column)
August 31, 2010... First Uranium Corp has announced that it has temporarily closed its Ezulwini Uranium plant to replace two columns in the ion exchange section, following a structural failure on a loading column. The plant will be closed while two columns are...

Magic-Seal Packaging Products to introduce first Vytex natural rubber latex napkin rings..
August 31, 2010... Vystar Corp has announced that Magic-Seal Packaging Products of Columbus, OH, will introduce the first napkin rings made from Vytex NRL. The new product will be marketed to the restaurant and hospitality industries through Magic Seal 's...

Enerkem announces construction start of world 's first municipal waste-to-biofuels facility in Edmonton, Alberta.
August 31, 2010... Enerkem Inc held a ceremony to signify the start of construction of its municipal waste-to-biofuels facility with its partners, the City of Edmonton and the Government of Alberta. Enerkem's advanced biofuels plant, which will be located in...

Reportlinker Adds US Plastic Containers Market.
August 31, 2010... Reportlinker.com has announced that a new market research report is available in its catalogue, US Plastic Containers Market. US demand for plastic containers is expected to exceed $30 bn in 2014, with resin demand approaching 14 bn pounds....

Reportlinker adds Global and China Titanium Industry Report, 2009-2010.(Industry overview)(Report)
August 31, 2010... Reportlinker com announces that a new market research report is available in its catalogue: Global and China Titanium Industry Report, 2009-2010. Titanium, an important strategic metal, has many advantages such as high specific strength,...

Reportlinker adds Global and China Carbon Fibre Industry Report-2010.(Report)
August 31, 2010... Reportlinker com announces that a new market research report is available in its catalogue: Global and China Carbon Fibre Industry Report-2010. Currently, the technology and production of carbon fibre globally is still under the control of Japan...

Reportlinker adds world flavours & fragrances market.
August 31, 2010... Reportlinker announces that a new market research report is available in its catalogue: World Flavors & Fragrances Market. Global demand to rise 4.3%/y through 2014. Worldwide demand for flavours and fragrances including flavour and...

A Schulman Realigns Crumlin, UK Manufacturing Operation, moves capacity to plants in Belgium and France.
August 31, 2010... A Schulman Inc is streamlining manufacturing operations at its Crumlin, South Wales, UK, production facility, and moving part of the plant 's capacity to two other, larger plants in Europe. As a result of the realignment, several production...

DuPont Titanium Technologies announces a price increase for all Ti-Pure titanium dioxide products sold in Asia Pacific.
August 31, 2010... DuPont Titanium Technologies announced a price increase for all DuPont Ti-Pure titanium dioxide grades sold in the Asia Pacific region. Effective 1 Oct 2010. Net prices for all titanium dioxide grades will increase by $150/tonne in Asia Pacific....

Mitsubishi Electric PV modules chosen for landmark solar project at Butte College.
August 31, 2010... Using solar energy, Butte College in Oroville, CA, plans to be one of the first colleges in the US to produce more energy than it consumes. While the college has been using solar energy since 2007, the board of trustees approved its Phase III...

Pall Corp awarded contract by JGC-Tecnimont.
August 31, 2010... Pall Corp has been contracted to supply critical enabling technologies for the Habshan 5 natural gas treatment plant being constructed by Abu Dhabi Gas Industries Ltd in the UAE. A joint venture of Tecnimont SpA, an Italian engineering...

XcelPlus Global introduces new name - Clean Energy Pathways and launches new website.
August 31, 2010... XcelPlus Global Holdings Inc has announced that effective 26 Aug 2010, the company's name has changed to Clean Energy Pathways Inc (Clean Energy). In conjunction with the name change, the company launched a new website...

Standard Solar ranks in top 100 of the 2010 Inc 500 Fastest Growing Private company in America list.
August 31, 2010... Standard Solar Inc has announced that the company was named to the prestigious Inc magazine Top 500 Fastest Growing Companies in America list, a compendium of the most entrepreneurial and fastest growing companies in America. Standard Solar...

REC wins Solar Industry Award for Module Manufacturing Innovation.
August 31, 2010... REC Peak Energy Module wins Solar Industry Award for Module Manufacturing Innovation. The Solar Industry Awards, presented by Solar PV Management Magazine, recognize innovative products and manufacturing processes across the photovoltaic value...

Rivaroxaban successfully demonstrated non-inferiority compared to standard of care for the prevention of recurrent venous thromboembolism in pivotal Phase III study.
August 31, 2010... Johnson & Johnson Pharmaceutical Research & Development LLC (J&JPRD), announced that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care for the prevention of...

Combination therapy of telmisartan and amlodipine provides significantly better blood pressure lowering than either agent alone.
August 31, 2010... Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe...

pSivida announces Iluvien receives FDA priority review for treatment of diabetic macular edema.
August 31, 2010... pSivida Corp announced that its licensee, Alimera Sciences has been notified that the US Food and Drug Administration (FDA) has granted Priority Review status for the New Drug Application (NDA) filed for Iluvien for the treatment diabetic...

Stromedix receives FDA orphan drug designation for STX-100 for the treatment of idiopathic pulmonary fibrosis.
August 31, 2010... Stromedix Inc announced that its lead clinical candidate STX-100 has been granted orphan drug status by the US Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF), a debilitating and almost uniformly fatal...

Pharmaxis selects Quintiles to provide comprehensive commercial solutions for Bronchitol launch.
August 31, 2010... Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol, an innovative treatment for cystic fibrosis. As a result of the agreement, Quintiles will...

Ovatech reports successful completion of Phase II clinical trial of Ovaprene non-hormonal intravaginal contraceptive ring.
August 31, 2010... Ovatech, an emerging women's health focused company, announced that the company's Phase II clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all'...

Vetter opens new sales office at Illinois Science + Technology Park in suburban Chicago.(Company overview)
August 31, 2010... In keeping with its strategy of US growth and expansion, Vetter has opened a new sales office at the Illinois Science + Technology Park in Skokie. The new office replaces its Yardley, Pennsylvania sales office, founded in 1983 as Vetter...

Sun Pharma announces USFDA approval for generic Strattera Capsules.
August 31, 2010... Sun Pharmaceutical Industries Ltd announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera, atomoxetine hydrochloride capsules. These generic atomoxetine...

Shionogi announces positive outcome to the decentralized procedure for the European approval of Twinject.
August 31, 2010... Shionogi Inc, a US-based group company of Shionogi & Co Ltd announced a positive outcome to the European decentralized procedure for the approval of Twinject (epinephrine auto-injector) following a communication from the UK Regulatory...

Quidel announces FDA clearance of its RapidVue hCG pregnancy lateral flow diagnostic test.
August 31, 2010... Quidel Corp, a leading provider of rapid diagnostic testing solutions, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the sale of Quidel's RapidVue hCG test, a lateral flow pregnancy...

PerkinElmer agrees to sell illumination and detection solutions business to Veritas Capital for approximately $500 M.
August 31, 2010... PerkinElmer Inc a global leader focused on improving the health and safety of people and the environment announced that it has agreed to sell its Illumination and Detection Solutions (IDS) business to Veritas Capital Fund III LP, a New...

BioCision LLC, eBioscience Inc forge cross-promotional collaboration.
August 31, 2010... BioCision LLC the CoolRack company, and eBioscience announced that they have entered into a cross-promotional agreement for their products. As part of eBioscience's 10th Anniversary promotional campaign that begins in Oct 2010, top-tier...

Conway reaches settlement with GlaxoSmithKline.
August 31, 2010... Kentucky Attorney General Jack Conway's office has reached a $3.75 M settlement between the state and GlaxoSmithKline PLC over the alleged deceptive or false marketing of the drugmaker's anti-nausea medications, most notably Kytril and Zofran....

Selexis SA and Biocrates Life Sciences GmbH join forces to further optimize high-yield mammalian cell cultures for the production of protein pharmaceuticals.
August 31, 2010... Austrian Biocrates Life Sciences AG (Biocrates) and Swiss Selexis SA have entered into a co-development agreement to further increase drug substance yields from mammalian cell cultures. Because most protein therapeutics require specific...

Allergan, Inc receives FDA approval for LUMIGAN 0.01% as first-line therapy indicated for the reduction of elevated intraocular pressure in glaucoma patients.
August 31, 2010... Allergan Inc announced the US Food and Drug Administration (FDA) has approved LUMIGAN (bimatoprost ophthalmic solution) 0.01% as a first-line therapy indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle...

ImmuneRegen BioSciences invited to submit full proposal to BARDA for Homspera as a potential medical countermeasure for injury associated with radiation exposure.
August 31, 2010... ImmuneRegen BioSciences (ImmuneRegen), a wholly owned subsidiary of IR Biosciences Holdings Inc, announced that after review of the company's proposal outline submitted in late 2009 advocating the development of Homspera as a medical...

National Institute of Allergy And Infectious Diseases (NIAID) grant to fund Dynavax Technologies Corp research on hepatitis B vaccination and individual variations in human responsiveness.
August 31, 2010... Dynavax Technologies Corp announced a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to take a systems biology approach to study the differences between individuals that do or do not respond to vaccination against...

RecipharmCobra Biologics announces patent for novel antibiotic-free plasmid maintenance system.
August 31, 2010... RecipharmCobra Biologics (RecipharmCobra) has been granted European and US patents for its novel plasmid maintenance system. Classically, genes of interest are inserted into plasmids with antibiotic resistance genes and then inserted into E coli...

Lab21 Ltd launches new commercial companion diagnostic service for HIV tropism in UK.
August 31, 2010... Lab21 Ltd announced the addition of a new diagnostic test for HIV to its portfolio of companion diagnostic services. Lab21 will be the first commercial reference laboratory in the UK to provide a companion diagnostic service for the HIV drug,...

Study shows Dermacyte Oxygen Concentrate appears to improve the appearance of fine lines and the perception of skin appearance.
August 31, 2010... Oxygen Biotherapeutics Inc announced that results from an 8-week cosmetic study showed that the topical application of Dermacyte Oxygen Concentrate, an oxygen-rich skin care lotion, appears to improve the appearance of fine lines and the...

Niusule Biotech Corp announces strategic distribution agreement with China's largest drug chain store China Nepstar.
August 31, 2010... Niusule Biotech Corp (Niusule) announced that it has signed a distribution agreement with China Nepstar Chain Drugstore Ltd (China Nepstar), China's largest retail drugstore chain based on the number of directly operated stores. The agreement,...

Auris Medical AG release: otoprotective effect of AM-111 also shown in model of cochlear ischemia.
August 31, 2010... Auris Medical's novel intracellular drug for the treatment of inner ear disorders, have been further confirmed by promising new data presented at the Inner Ear Biology Workshop 2010 in Prague (Czech Republic). A research group led by Prof...

Neurotech announces initiation of Phase I clinical trial for AAD-2004, a potent spin trapping molecule and microsomal prostaglandin E synthase-1 inhibitor, targeting Alzheimer's, Parkinson's, and Lou gehrig's disease.
August 31, 2010... Neurotech Pharmaceuticals Co Ltd (Neurotech) has begun dosing in the Phase I clinical testing of AAD-2004. AAD-2004 was developed as a dual function drug to remove free radicals and PGE2, the key mediators of nerve injury in Alzheimer's disease...

Stromedix Inc receives FDA orphan drug designation for STX-100 for the treatment of idiopathic pulmonary fibrosis.
August 31, 2010... Stromedix Inc announced that its lead clinical candidate STX-100 has been granted orphan drug status by the US Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF), a debilitating and almost uniformly fatal...

GW Pharmaceuticals release: Health Canada grants full approval of Sativex for the treatment of spasticity due to multiple sclerosis.
August 31, 2010... GW Pharmaceuticals plc and Bayer Inc announced that Health Canada has approved Sativex [delta-9-tetrahydrocannabinol 27 mg/ml (from Tetrabinex - cannabis sativa L extract) and cannabidiol 25 mg/ml (from Nabidiolex - cannabis sativa L extract)]...

Covidien sells CPAP, speciality chemical unit.
August 31, 2010... Covidien said on 30 Aug 2010 in separate announcements that it completed the previously announced sales of its speciality chemical business and its sleep therapy product line. Covidien agreed in May 2010 to sell its speciality chemicals business...

Lonza Group Ltd acquires viral vaccine and vector manufacturer Vivante GMP Solutions.
August 31, 2010... Lonza enters the viral based-manufacturing market on 31 Aug 2010 with its purchase of Vivante GMP Solutions Inc (Vivante). The acquisition advances Lonza's strategy to broaden its biologics custom service offering for the growing viral vaccine...

Alimera Sciences' Iluvien receives FDA Priority Review for the treatment of diabetic macular edema.
August 31, 2010... Alimera Sciences Inc (Alimera) announced that the company's New Drug Application (NDA) for Iluvien (fluocinolone acetonide intravitreal insert) has been accepted for filing and granted Priority Review status by the US Food and Drug...

BTG plc signs $16.6 M deal to sell Nycomed's antivenom drugs.
August 31, 2010... BTG plc has signed an agreement with Nycomed US Inc concerning the accelerated transition to BTG on 1 Oct 2010 of marketing rights to CroFab [Crotalidae Polyvalent Immune Fab (Ovine)], an antivenom, and DigiFab [Digoxin Immune Fab (Ovine)], for...

Brazil's Jul 2010 industrial output up 0.4% versus Jun 2010; +8.7% on year.
August 31, 2010... The Brazilian Census Bureau reported 0.4% increased industrial output for Jul 2010 as against to Jun 2010. Further, the industrial production rose 8.7% for Jul 2010 as against to Jul 2009. Meanwhile, chemical products production increased by 3%,...

LyondellBasell new-generation PP resin selected for rainwater management system at Berlin airport.
August 31, 2010... LyondellBasell's Hostalen PP N2122 resin is being used to produce infiltration pipes for the rainwater management system at the new Berlin-Brandenburg International (BBI) Airport, one of Europe's largest currently under construction. The...